Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...
The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...
Global NICU Genetic Testing Market OverviewThe global NICU Genetic Testing Market is projected to grow at a CAGR of ...
As genetic analysis expands to serve everything from population-scale studies to precision-driven clinical decisions, laboratories are under growing pressure to move faster while managing increasingly ...
Affymetrix Inc. announced that the US Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The ...
Astra Biotech GmbH is in the pre-launch phase of its newly developed test, based on microarray technology, for rapid simultaneous detection of 25 of the most common mutations causing cystic fibrosis ...
Rare diseases often remain undiagnosed for long periods, not because symptoms are absent, but because they may be subtle, overlapping, or easily misinterpreted in clinical settings. Early recognition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results